Fig. 2From: Genomics of drug sensitivity in bladder cancer: an integrated resource for pharmacogenomic analysis in bladder cancerDrug sensitivity of EGFR inhibitors in bladder cancer cell lines. Bladder cancer cell lines with high expression of EGFR, including HT1376, 5637 and UBLC1, were markedly sensitive to EGFR-targeting agents. The average IC50 is the average sensitivity of those drugs in different available cell lines across CTRPBack to article page